0000000000562473

AUTHOR

Mariarita Caroleo

showing 5 related works from this author

Metacognition and emotion regulation as treatment targets in binge eating disorder: a network analysis study

2021

Abstract Background This study aims to examine the underlying associations between eating, affective and metacognitive symptoms in patients with binge eating disorder (BED) through network analysis (NA) in order to identify key variables that may be considered the target for psychotherapeutic interventions. Methods A total of 155 patients with BED completed measures of eating psychopathology, affective symptoms, emotion regulation and metacognition. A cross-sectional network was inferred by means of Gaussian Markov random field estimation using graphical LASSO and the extended Bayesian information criterion (EBIC-LASSO), and central symptoms of BED were identified by means of the strength c…

Nutrition and Dieteticslcsh:RC435-571MetacognitionInterpersonal communicationEmotion dysregulationmedicine.diseaseImpulse controlPsychotherapyBehavioral NeurosciencePsychiatry and Mental healthEating disordersBinge-eating disorderBinge eating disorderlcsh:PsychiatrymedicineNetwork analysisBinge severityPsychologyCentralityMetacognitionResearch ArticleNetwork analysisClinical psychologyPsychopathologyJournal of Eating Disorders
researchProduct

Additional file 1 of Metacognition and emotion regulation as treatment targets in binge eating disorder: a network analysis study

2021

Additional file 1: Figure S1. Results of case-dropping subset bootstrap procedure to assess stability of network centrality indices. Average correlations between centrality indices of networks sampled with persons dropped and the original sample.

researchProduct

Additional file 2 of Metacognition and emotion regulation as treatment targets in binge eating disorder: a network analysis study

2021

Additional file 2: Figure S2. Bootstrapped confidence intervals (#boots = 2000) for estimated edge-weights of BED patients.

researchProduct

Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Ne…

2022

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with th…

Long-acting injectable antipsychoticCross-Sectional StudiesOff-labelPersonality disorderBipolar disorderDelayed-Action PreparationsSchizophreniaHumansBipolar disorder; Long-acting injectable antipsychotics; Off-label; Personality disorder; Schizophrenia; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Off-Label Use; Antipsychotic Agents; SchizophreniaOff-Label UseSettore MED/25 - PsichiatriaLong-acting injectable antipsychoticsAntipsychotic Agents
researchProduct

Data from: Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy

2019

Background. For many years, long-acting intramuscular (LAI) antipsychotics have been prescribed predominantly to chronic and severe patients, as a last resort when other treatments failed. Recently, a broader and earlier use of LAIs, particularly second-generation LAIs, has been emphasized. To date, few studies attempted to frame how this change in prescribing took place in real-world practice. Therefore, this study aimed to describe the clinical features of patients prescribed with LAIs, and to explore possible prescribing differences between first- and second-generations LAIs under ordinary clinical practice in Italy. Methods. The STAR Network "Depot" Study is an observational, longitudin…

bipolar disorderpharmacoepidemiologyvirusesLife Sciencesvirus diseaseslong-acting injectable antipsychoticsadherence to antipsychoticsDecember 2015-May 2017medicine and health careschizophreniaantipsychoticsimmune system diseasesMedicineoff-label prescriptionsdepot antipsychotics
researchProduct